In Vivo Target Gene Activation via CRISPR/Cas9-Mediated Trans-epigenetic Modulation …………… Liao HK, Hatanaka F, Araoka T, Reddy P, Wu MZ, Sui Y, Yamauchi T, Sakurai M, O’Keefe DD, Núñez-Delicado E, Guillen P, Campistol JM, Wu CJ, Lu LF, Esteban CR, Izpisua Belmonte JC. Cell. 2017 Dec 14;171(7):1495-1507. PubMed 00
Aptamer-conjugated extracellular nanovesicles for targeted drug delivery …………… Wan Y, Wang L, Zhu C, Zheng Q, Wang G, Tong J, Fang Y, Xia Y, Cheng G, He X, Zheng SY. Cancer Res. 2017 Dec 7. pii: canres.2880.2017. PubMed 00
Multi-targeted effects of G4-aptamers and their antiproliferative activity against cancer cells …………… Ogloblina AM, Khristich AN, Karpechenko NY, Semina SE, Belitsky GA, Dolinnaya NG, Yakubovskaya MG. Biochimie. 2017 Dec 5. pii: S0300-9084(17)30329-2. PubMed 00
Aptamer-Targeted Plasmonic Photothermal Therapy of Cancer …………… Kolovskaya OS, Zamay TN, Belyanina IV, Karlova E, Garanzha I, Aleksandrovsky AS, Kirichenko A, Dubynina AV, Sokolov AE, Zamay GS, Glazyrin YE, Zamay S, Ivanchenko T, Chanchikova N, Tokarev N, Shepelevich N, Ozerskaya A, Badrin E, Belugin K, Belkin S, Zabluda V, Gargaun A, Berezovski MV, Kichkailo AS.…